WHO gears up for global mega-trial of potential coronavirus vaccines
The solidarity vaccine trial is WHO's all-out, coordinated push to test all the potential vaccines for COVID-19 and find the effective one(s).
Known as the Solidarity vaccine trial, it is WHO's all-out, coordinated push to test all the potential vaccines and find the effective one(s).
In it's draft proposal, WHO says that this large, international, multi-site, individually randomised controlled clinical trial will enable the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3-6 months of it entering the trail.
With many scientists and researchers across the globe racing against time to invent the vaccine, this mega-trial aims to evaluate their safety and efficacy; and whether any are fit for deployment to influence the course of the pandemic.
Under this inetrnationa trial, vaccines may be added to the trial as they become available if they meet prioritisation criteria. WHO believes that this study will achieve reliable results within 3-6 months of receiving sufficient supplies from the vaccine developer.
Under this all the partcipating vaccines will be centrally randomised so that each of them get equal opportunity of testing. Which will also mean that all the countries across the world will have an equity of access as and when they're ready.
According to WHO, all sites with sufficient transmission rate across the world can participate in this trial.
A single steering committe and a single data monitoring committee from WHO will monitor and coordinate this global trial and will ensure that the study progesses as spelled out.
Earlier, India had volunteered to participate in the solidarity trial when the number of positive cases started spiking since the end of March. Many countries, including Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland, and Thailand, had already confirmed that they will join the solidarity trial, according to WHO.